NB

Nitin Bansal

Active Director Director DIN 09640107
DIN 09640107 First appointment Jun 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Nitin Bansal

Data last updated:

Nitin Bansal is a Director at Dengen Healthcare Private Limited (since 2022). The company operates in Healthcare. Dengen Healthcare Private Limited reported revenue of ₹3.19 Cr (FY 2024).

DIN 09640107
Primary Designation Director
Industry Healthcare
First Appointment 16 Jun 2022
Oldest Company Age 4 yrs
Largest company Dengen Healthcare Private Limited · ₹3.19 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dengen Healthcare Private Limited U33119HR2022PTC104405
Director16 Jun 20222022₹3.19 Cr (FY 2024)Active

Board colleagues of Nitin Bansal

Directorship timeline

Open interactive timeline →
Dengen Healthcare Private Limited
Premium access

Shareholding and investment profile for Nitin Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Bansal

Nitin Bansal currently holds 1 directorship: Dengen Healthcare Private Limited (Director, since 16 Jun 2022, revenue ₹3.19 Cr (FY 2024)).

Nitin Bansal was first appointed on 16 Jun 2022 as Director at Dengen Healthcare Private Limited.

The current boards of Nitin Bansal's companies include Narender Bansal (Dengen Healthcare Private Limited), Naresh Kumar Bansal (Dengen Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available